Diisopropylethylamine → HCID 178522267, compound

HRID 522085Notes

Reaction equation

HRID 522085 reaction equation
[Cl:1][C:2]1[CH:24]=[CH:23][C:22]([C:25]2[C:30]([F:31])=[CH:29][CH:28]=[CH:27][N:26]=2)=[CH:21][C:3]=1[C:4]([NH:6][C:7]1[N:11](C2C=CC=CC=2)[N:10]=[C:9]([C:18]([OH:20])=O)[CH:8]=1)=[O:5].C(N([CH:38]([CH3:40])[CH3:39])CC)(C)C.C[Si](C)(C)CCOC[N:47]1[CH:51]=[C:50]([CH2:52][CH2:53][NH2:54])[N:49]=[N:48]1.C[Si](C)(C)CCOCN1N=[C:66]([CH2:68]CN)[CH:65]=N1.C[Si](C)(C)CCOCN1C(CCN)=CN=N1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C)C=O>[NH:47]1[CH:51]=[C:50]([CH2:52][CH2:53][NH:54][C:18]([C:9]2[N:10]([C:39]3[CH:38]=[CH:40][CH:68]=[CH:66][CH:65]=3)[N:11]=[C:7]([NH:6][C:4](=[O:5])[C:3]3[CH:21]=[C:22]([C:25]4[C:30]([F:31])=[CH:29][CH:28]=[CH:27][N:26]=4)[CH:23]=[CH:24][C:2]=3[Cl:1])[CH:8]=2)=[O:20])[N:49]=[N:48]1

Participants

8

Procedure

To a solution of 5-(2-chloro-5-(3-fluoropyridin-2-yl)benzamido)-1-phenyl-1H-pyrazole-3-carboxylic acid (Example 105, 250 mg, 0.57 mmol) and diisopropylethylamine (350 μL, 2.0 mmol)) in dimethylformamide (5 mL) was added a mixture of 2-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,3-triazol-4-yl)ethanamine and 2-(2-((2-(trimethylsilyl)ethoxy)methyl)-2H-1,2,3-triazol-4-yl)ethanamine and 2-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,3-triazol-5-yl)ethanamine (Preparation 65, 210 mg, 0.84 mmol). The mixture was stirred for 5 minutes before the addition of HATU (220 mg, 0.57 mmol). The reaction was stirred at room temperature for 18 hours and concentrated in vacuo. The residue was partitioned between EtOAc (80 mL) and dilute aqueous sodium hydrogen carbonate solution (80 mL) with saturated aqueous sodium chloride solution (10 mL). The organic layer was collected, dried over anhydrous sodium sulphate and concentrated in vacuo. The residue was dissolved in DCM (20 mL) and treated with TFA (20 mL) with stirring at room temperature for 18 hours. After concentration in vacuo, the residue was partitioned between DCM (80 mL) with MeOH (4 mL) and dilute aqueous sodium hydrogen carbonate solution (50 mL). The organic layer was collected, dried over sodium sulphate and concentrated in vacuo. The residue was purified using silica gel column chromatography eluting with 95:5:0.5 to 90.10:1 DCM:MeOH:NH3 followed by dissolving in hot MeCN (15 mL). The solution was cooled and decanted to afford a residue that was azeotroped with toluene and water to afford the title compound (31 mg, quant.).

Workup

  1. concentrationconcentrated in vacuo
  2. customThe residue was partitioned between EtOAc (80 mL) and dilute aqueous sodium hydrogen carbonate solution (80 mL) with saturated aqueous sodium chloride solution (10 mL)
  3. customThe organic layer was collected
  4. dry with materialdried over anhydrous sodium sulphate
  5. concentrationconcentrated in vacuo
  6. dissolutionThe residue was dissolved in DCM (20 mL)
  7. additiontreated with TFA (20 mL)
  8. stirringwith stirring at room temperature for 18 hours
  9. concentrationAfter concentration in vacuo
  10. customthe residue was partitioned between DCM (80 mL) with MeOH (4 mL) and dilute aqueous sodium hydrogen carbonate solution (50 mL)
  11. customThe organic layer was collected
  12. dry with materialdried over sodium sulphate
  13. concentrationconcentrated in vacuo
  14. customThe residue was purified
  15. washeluting with 95:5:0.5 to 90.10:1 DCM
  16. dissolutionby dissolving in hot MeCN (15 mL)
  17. temperatureThe solution was cooled
  18. customdecanted
  19. customto afford a residue that
  20. customwas azeotroped with toluene and water

Sources & evidence

ORD record
ord-c4b26ffcff084ba08fa521faa1208343
Source dataset
uspto-grants-2016_05
Patent number
US09328096B2

Reaction notes

Loading…